CAPTRUST Financial Advisors’s Bio-Path Holdings Inc BPTH Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BPTH Stock Details BPTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13	Closed	-$1K	–	4337
2022 Q2	$1K	Hold	13	–	–	﹤0.01%	4801
2022 Q1	$1K	Hold	13	–	–	﹤0.01%	4784
2021 Q4	$1K	Buy	+13	New	+$1.2K	﹤0.01%	4669
2021 Q2	–	Sell	-13	Closed	-$2K	–	4696
2021 Q1	$2K	Buy	+13	New	+$1.54K	﹤0.01%	4096
2019 Q4	–	Sell	-13	Closed	-$2K	–	1894
2019 Q3	$2K	Hold	13	–	–	﹤0.01%	1821
2019 Q2	$3K	Hold	13	–	–	﹤0.01%	1764
2019 Q1	$5K	Hold	13	–	–	﹤0.01%	1553
2018 Q4	$1K	Hold	13	–	–	﹤0.01%	1560
2018 Q3	$3K	Hold	13	–	–	﹤0.01%	1454
2018 Q2	$7K	Hold	13	–	–	﹤0.01%	1278
2018 Q1	$9K	Buy	+13	New	+$10.1K	﹤0.01%	1066

Other funds holding BPTH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MYIA

Mount Yale Investment Advisors Denver, Colorado $4.31B AUM 21.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CAPTRUST Financial Advisors's BPTH Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Bio-Path Holdings Inc (BPTH) in Q3 2022, closing a stake of 13 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in BPTH in Q1 2018 and held it in 11 quarters. The position peaked at $9K in Q1 2018. 19 funds tracked by Wall St. Rank hold BPTH as of Q3 2022.

CAPTRUST Financial Advisors reported no remaining Bio-Path Holdings Inc position as of Q3 2022 after selling out during the quarter.
CAPTRUST Financial Advisors sold 13 Bio-Path Holdings Inc shares in Q3 2022, an estimated $1K.
CAPTRUST Financial Advisors first reported a position in Bio-Path Holdings Inc in Q1 2018 and held it in 11 quarters.
CAPTRUST Financial Advisors's Bio-Path Holdings Inc position peaked at $9K in Q1 2018.
19 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.